We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.65B
Cap. Flow
% of AUM
97.21%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$91.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$79.7M |
| 3 |
Apple
AAPL
|
+$78.2M |
| 4 |
Qualcomm
QCOM
|
+$73.5M |
| 5 |
Amgen
AMGN
|
+$71.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.7% |
| 4 | Industrials | 8.01% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LXFT
201
DELISTED
Luxoft Holding, Inc.
LXFT
| $6.06M | 0.13% |
+157,475
| New | +$5.96M |
|
202
TG Therapeutics
TGTX
$8.58B
| $6.02M | 0.13% |
+380,000
| New | +$4.95M |
|
|
SWN
203
DELISTED
Southwestern Energy Company
SWN
| $6.01M | 0.13% |
+220,270
| New | +$7.08M |
|
204
Bio-Techne
TECH
$11.2B
| $5.82M | 0.12% |
+252,000
| New | +$5.77M |
|
205
East-West Bancorp
EWBC
$17.9B
| $5.81M | 0.12% |
+150,000
| New | +$5.43M |
|
|
FOLD
206
DELISTED
Amicus Therapeutics
FOLD
| $5.78M | 0.12% |
+695,000
| New | +$4.77M |
|
207
Akamai
AKAM
$16.8B
| $5.77M | 0.12% |
+91,678
| New | +$5.53M |
|
|
FITB
208
Fifth Third Bancorp
FITB
$52B
| $5.77M | 0.12% |
+283,250
| New | +$5.62M |
|
209
McKesson
MCK
$98.5B
| $5.74M | 0.12% |
+27,649
| New | +$5.62M |
|
210
Union Pacific
UNP
$183B
| $5.73M | 0.12% |
+48,130
| New | +$5.53M |
|
211
3M
MMM
$89B
| $5.69M | 0.12% |
+41,434
| New | +$5.32M |
|
212
Kinross Gold
KGC
$28.5B
| $5.67M | 0.12% |
+2,014,228
| New | +$5.65M |
|
|
FDO
213
DELISTED
FAMILY DOLLAR STORES
FDO
| $5.66M | 0.12% |
+71,500
| New | +$5.61M |
|
|
KERX
214
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $5.52M | 0.12% |
+390,000
| New | +$6.04M |
|
|
ICPT
215
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.46M | 0.11% |
+35,000
| New | +$6.46M |
|
216
McDonald's
MCD
$188B
| $5.45M | 0.11% |
+58,152
| New | +$5.44M |
|
217
Capri Holdings
CPRI
$1.77B
| $5.34M | 0.11% |
+71,129
| New | +$5.3M |
|
|
MON
218
DELISTED
Monsanto Co
MON
| $5.31M | 0.11% |
+44,422
| New | +$5.16M |
|
219
Acadia Pharmaceuticals
ACAD
$4.25B
| $5.24M | 0.11% |
+165,000
| New | +$4.68M |
|
|
TIF
220
DELISTED
Tiffany & Co.
TIF
| $5.24M | 0.11% |
+48,987
| New | +$4.9M |
|
221
CVS Health
CVS
$137B
| $5.2M | 0.11% |
+54,030
| New | +$4.76M |
|
222
PTC Therapeutics
PTCT
$6.37B
| $5.18M | 0.11% |
+100,000
| New | +$4.4M |
|
223
Brown-Forman Class B
BF.B
$12B
| $5.08M | 0.11% |
+180,766
| New | +$5.23M |
|
224
Honeywell
HON
$77.1B
| $5.08M | 0.11% |
+56,574
| New | +$4.87M |
|
|
TSRO
225
DELISTED
TESARO, Inc.
TSRO
| $5.06M | 0.11% |
+136,000
| New | +$4.2M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Candriam SCA, which disclosed 616 positions worth $4.78B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is Gilead Sciences: 888,125 shares worth $83.7M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Technology.
- Candriam SCA's largest Q4 2014 buy was Gilead Sciences: 888,125 shares worth $83.7M.
- Candriam SCA's ten largest holdings make up 14% of its $4.78B portfolio in Q4 2014.
- Candriam SCA disclosed 616 positions in Q4 2014, its first 13F filing on record.
Based on Candriam SCA's 13F filing for Q4 2014, filed 26 Mar 2015.